UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Preliminary analysis of ECOG 3303: Concurrent radiation (RT), cisplatin (DDP) and cetuximab (C) in unresectable, locally advanced (LA) squamous cell carcinoma of the head and neck (SCCHN)

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.6006-6006

2008

Volltextzugriff (PDF)

Randomized, double-blind, placebo-controlled phase II study of carboplatin and paclitaxel with or without vorinostat, a histone deacetylase inhibitor (HDAC), for first-line therapy of advanced non-small cell lung cancer (NCI 7863)

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.8004-8004

2009

Volltextzugriff (PDF)

Phase I trial of cetuximab (C) and dasatinib (D) in patients (pts) with advanced solid malignancies

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.14668-14668

2008

Volltextzugriff (PDF)

Phase II study of RAD001 (Everolimus) in previously treated small cell lung cancer (SCLC)

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.19017-19017

2008

Volltextzugriff (PDF)

Prognostic factors in patients with locally advanced salivary gland cancers treated with surgery and postoperative radiotherapy (RT)

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.6045-6045

2008

Volltextzugriff (PDF)

Pemetrexed (P) and bevacizumab (B) in patients (pts) with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC): updated results of a phase II trial

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.6069-6069

2008

Volltextzugriff (PDF)

Utilization of gastrostomy tubes during chemoradiotherapy for head and neck cancer: The University of Pittsburgh experience

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.20657-20657

2008

Volltextzugriff (PDF)

Cetuximab (C) and bevacizumab (B) in patients with recurrent or metastatic head and neck squamous cell carcinoma (SCCHN): An interim analysis

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.6072-6072

2008

Volltextzugriff (PDF)

Phase II trial of neoadjuvant docetaxel (T), cisplatin (P), and cetuximab (E) followed by concurrent radiation (X), P, and E in locally advanced head and neck cancer (HNC)

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.6002-6002

2008

Volltextzugriff (PDF)

How to best assess tumor response after curative chemoradiotherapy (CRT) for head and neck squamous cell carcinomas (HNSCC): RECIST or PET/CT?

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.6023-6023

2008

Volltextzugriff (PDF)

Phase I trial of pemetrexed, cetuximab, and concurrent radiotherapy (RT) in head and neck cancer (HNC)

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.2540-2540

2008

Volltextzugriff (PDF)

Erlotinib (E) as adjuvant treatment for patients (pts) with resected head and neck squamous cell carcinoma (HNSCC) with evaluation of neoadjuvant biomarker modulation with E with or without sulindac (S): a feasibility report

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.6037-6037

2008

Volltextzugriff (PDF)

Carboplatin and Paclitaxel in Combination With Either Vorinostat or Placebo for First-Line Therapy of Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2010-01, Vol.28 (1), p.56-62

2010

Volltextzugriff (PDF)

Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors

Annals of oncology, 2016-02, Vol.27 (2), p.318-323

2016

Volltextzugriff (PDF)

Phase II randomized trial of radiation therapy, cetuximab, and pemetrexed with or without bevacizumab in patients with locally advanced head and neck cancer

Annals of oncology, 2016-08, Vol.27 (8), p.1594-1600

2016

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Study of Vorinostat, A Histone Deacetylase Inhibitor, in Combination with Carboplatin and Paclitaxel for Advanced Solid Malignancies

Clinical cancer research, 2007-06, Vol.13 (12), p.3605-3610

2007

Volltextzugriff (PDF)

Dependence of magnetic permeability on residual stresses in alloyed steels

AIP advances, 2018-04, Vol.8 (4), p.047201-047201-4

2018

Volltextzugriff (PDF)

Phase II Trial of Pemetrexed and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer

Journal of clinical oncology, 2011-03, Vol.29 (9), p.1140-1145

2011

Volltextzugriff (PDF)

Phase 3 Trial of Ibrutinib plus Rituximab in Waldenström’s Macroglobulinemia

The New England journal of medicine, 2018-06, Vol.378 (25), p.2399-2410

2018

Volltextzugriff (PDF)

The Lipoprotein Transport System in the Pathogenesis of Multiple Myeloma: Advances and Challenges

Frontiers in oncology, 2021-03, Vol.11, p.638288-638288

2021

Volltextzugriff (PDF)

Dealing with stress during tennis competition. The association of approach- and avoidance-coping with metacognition and achievement goal theory perspectives

Journal of Physical Education and Sport, 2018-12, Vol.18 (4), p.2454-2465

2018

Volltextzugriff (PDF)

Magnetic evaluation of Bauschinger effect in marine engineering steels

NDT & E international : independent nondestructive testing and evaluation, 2023-10, Vol.139, p.102933, Article 102933

2023

Volltextzugriff (PDF)

670P Discordant pathologic tumor response in primary tumors and lymph nodes after neoadjuvant immune checkpoint inhibition (ICI) in head and neck squamous cell carcinoma (HNSCC)

Annals of oncology, 2022-09, Vol.33, p.S849

2022

Volltextzugriff (PDF)

Induction Docetaxel, Cisplatin, and Cetuximab Followed by Concurrent Radiotherapy, Cisplatin, and Cetuximab and Maintenance Cetuximab in Patients With Locally Advanced Head and Neck Cancer

Journal of clinical oncology, 2010-12, Vol.28 (36), p.5294-5300

2010

Volltextzugriff (PDF)

Stereotactic Body Radiotherapy for Recurrent Squamous Cell Carcinoma of the Head and Neck: Results of a Phase I Dose-Escalation Trial

International journal of radiation oncology, biology, physics, 2009-12, Vol.75 (5), p.1493-1500

2009

Volltextzugriff (PDF)

1 – 25 von 220

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(213)
Mit Volltextzugriff
(211)

Publikationsform

Sprache

Englisch
(220)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(119)
Life Sciences & Biomedicine
(109)
Humans
(89)
Female
(65)
Male
(64)
Aged
(55)
Middle Aged
(53)
Oncology
(53)
Adult
(45)
Biological And Medical Sciences
(42)
Medical Sciences
(32)
Aged, 80 And Over
(30)
Medicin Och Hälsovetenskap
(28)
Animals
(27)
Hematology
(25)
Tumors
(25)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(22)
Head And Neck Neoplasms - Drug Therapy
(22)
Treatment Outcome
(22)
Neoplasm Staging
(20)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Preliminary analysis of ECOG 3303: Concurrent radiation (RT), cisplatin (DDP) and cetuximab (C) in unresectable, locally advanced (LA) squamous cell carcinoma of the head and neck (SCCHN)

Randomized, double-blind, placebo-controlled phase II study of carboplatin and paclitaxel with or without vorinostat, a histone deacetylase inhibitor (HDAC), for first-line therapy of advanced non-small cell lung cancer (NCI 7863)

Phase I trial of cetuximab (C) and dasatinib (D) in patients (pts) with advanced solid malignancies

Phase II study of RAD001 (Everolimus) in previously treated small cell lung cancer (SCLC)

Prognostic factors in patients with locally advanced salivary gland cancers treated with surgery and postoperative radiotherapy (RT)

Pemetrexed (P) and bevacizumab (B) in patients (pts) with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC): updated results of a phase II trial

Utilization of gastrostomy tubes during chemoradiotherapy for head and neck cancer: The University of Pittsburgh experience

Cetuximab (C) and bevacizumab (B) in patients with recurrent or metastatic head and neck squamous cell carcinoma (SCCHN): An interim analysis

Phase II trial of neoadjuvant docetaxel (T), cisplatin (P), and cetuximab (E) followed by concurrent radiation (X), P, and E in locally advanced head and neck cancer (HNC)

How to best assess tumor response after curative chemoradiotherapy (CRT) for head and neck squamous cell carcinomas (HNSCC): RECIST or PET/CT?

Phase I trial of pemetrexed, cetuximab, and concurrent radiotherapy (RT) in head and neck cancer (HNC)

Erlotinib (E) as adjuvant treatment for patients (pts) with resected head and neck squamous cell carcinoma (HNSCC) with evaluation of neoadjuvant biomarker modulation with E with or without sulindac (S): a feasibility report

Carboplatin and Paclitaxel in Combination With Either Vorinostat or Placebo for First-Line Therapy of Advanced Non–Small-Cell Lung Cancer

Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors

Phase II randomized trial of radiation therapy, cetuximab, and pemetrexed with or without bevacizumab in patients with locally advanced head and neck cancer

Phase I and Pharmacokinetic Study of Vorinostat, A Histone Deacetylase Inhibitor, in Combination with Carboplatin and Paclitaxel for Advanced Solid Malignancies

Dependence of magnetic permeability on residual stresses in alloyed steels

Phase II Trial of Pemetrexed and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer

Phase 3 Trial of Ibrutinib plus Rituximab in Waldenström’s Macroglobulinemia

The Lipoprotein Transport System in the Pathogenesis of Multiple Myeloma: Advances and Challenges

Dealing with stress during tennis competition. The association of approach- and avoidance-coping with metacognition and achievement goal theory perspectives

Magnetic evaluation of Bauschinger effect in marine engineering steels

670P Discordant pathologic tumor response in primary tumors and lymph nodes after neoadjuvant immune checkpoint inhibition (ICI) in head and neck squamous cell carcinoma (HNSCC)

Induction Docetaxel, Cisplatin, and Cetuximab Followed by Concurrent Radiotherapy, Cisplatin, and Cetuximab and Maintenance Cetuximab in Patients With Locally Advanced Head and Neck Cancer

Stereotactic Body Radiotherapy for Recurrent Squamous Cell Carcinoma of the Head and Neck: Results of a Phase I Dose-Escalation Trial

Suchergebnisse filtern